CompaniesHRA Pharma

HRA Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (17)
View all

Total Trials

17

As Lead Sponsor

14

As Collaborator

3

Total Enrollment

7,519

By Phase

PHASE3: 6PHASE2: 5PHASE4: 1PHASE1/PHASE2: 1

By Status

COMPLETED: 13TERMINATED: 2ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00290251
NCT00422201
NCT01569737
NCT02297945
NCT04872920
NCT05255900
Hover over trial bars to see details

Recent Trials

NCT05255900Collaborator
Effects of Metyrapone in Patients With Hypercortisolism
N/AActive, not recruiting
20 participants
Started: Apr 28, 2022 · Completed: Dec 31, 2025
NCT04112095Lead Sponsor
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
PHASE3Completed
962 participants
Started: Sep 6, 2019 · Completed: Aug 5, 2021
NCT04872920Lead Sponsor
Observational Registry on Patients With Endogenous CS to Document Safety and Effectiveness of Ketoconazole.
N/AUnknown
200 participants
Started: Dec 20, 2018 · Completed: Mar 1, 2024
NCT03585712Lead Sponsor
Effect of Norgestrel 75 mcg on Cervical Mucus and Ovarian Activity During Perfect Use, After One Delayed Intake and After a Missed Pill
PHASE2Completed
52 participants
Started: Jul 24, 2018 · Completed: Apr 7, 2020
NCT03559010Lead Sponsor
A Study of Oral Contraception Under Simulated OTC Conditions
PHASE3Terminated
189 participants
Started: Apr 27, 2018 · Completed: Nov 14, 2018
View all 17 trials →
Related Companies
Perrigo
acquired